These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 28219702)

  • 1. Genetic alterations in Krebs cycle and its impact on cancer pathogenesis.
    Sajnani K; Islam F; Smith RA; Gopalan V; Lam AK
    Biochimie; 2017 Apr; 135():164-172. PubMed ID: 28219702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial dysfunctions in cancer: genetic defects and oncogenic signaling impinging on TCA cycle activity.
    Desideri E; Vegliante R; Ciriolo MR
    Cancer Lett; 2015 Jan; 356(2 Pt A):217-23. PubMed ID: 24614286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Krebs cycle intermediates regulate DNA and histone methylation: epigenetic impact on the aging process.
    Salminen A; Kauppinen A; Hiltunen M; Kaarniranta K
    Ageing Res Rev; 2014 Jul; 16():45-65. PubMed ID: 24910305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gerometabolites: the pseudohypoxic aging side of cancer oncometabolites.
    Menendez JA; Alarcón T; Joven J
    Cell Cycle; 2014; 13(5):699-709. PubMed ID: 24526120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inborn and acquired metabolic defects in cancer.
    Frezza C; Pollard PJ; Gottlieb E
    J Mol Med (Berl); 2011 Mar; 89(3):213-20. PubMed ID: 21301796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isocitrate dehydrogenase (IDH), succinate dehydrogenase (SDH), fumarate hydratase (FH): three players for one phenotype in cancer?
    Laurenti G; Tennant DA
    Biochem Soc Trans; 2016 Aug; 44(4):1111-6. PubMed ID: 27528759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global transcription analysis of Krebs tricarboxylic acid cycle mutants reveals an alternating pattern of gene expression and effects on hypoxic and oxidative genes.
    McCammon MT; Epstein CB; Przybyla-Zawislak B; McAlister-Henn L; Butow RA
    Mol Biol Cell; 2003 Mar; 14(3):958-72. PubMed ID: 12631716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondria in cancer: at the crossroads of life and death.
    Fogg VC; Lanning NJ; Mackeigan JP
    Chin J Cancer; 2011 Aug; 30(8):526-39. PubMed ID: 21801601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of mitochondria on cancer treatment resistance.
    van der Merwe M; van Niekerk G; Fourie C; du Plessis M; Engelbrecht AM
    Cell Oncol (Dordr); 2021 Oct; 44(5):983-995. PubMed ID: 34244972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations.
    Pollard PJ; Brière JJ; Alam NA; Barwell J; Barclay E; Wortham NC; Hunt T; Mitchell M; Olpin S; Moat SJ; Hargreaves IP; Heales SJ; Chung YL; Griffiths JR; Dalgleish A; McGrath JA; Gleeson MJ; Hodgson SV; Poulsom R; Rustin P; Tomlinson IP
    Hum Mol Genet; 2005 Aug; 14(15):2231-9. PubMed ID: 15987702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired mitochondrial energy metabolism in Alzheimer's disease: Impact on pathogenesis via disturbed epigenetic regulation of chromatin landscape.
    Salminen A; Haapasalo A; Kauppinen A; Kaarniranta K; Soininen H; Hiltunen M
    Prog Neurobiol; 2015 Aug; 131():1-20. PubMed ID: 26001589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic changes associated with tumor metastasis, part 2: Mitochondria, lipid and amino acid metabolism.
    Porporato PE; Payen VL; Baselet B; Sonveaux P
    Cell Mol Life Sci; 2016 Apr; 73(7):1349-63. PubMed ID: 26646069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of mitochondrial dysfunction in cancer progression.
    Hsu CC; Tseng LM; Lee HC
    Exp Biol Med (Maywood); 2016 Jun; 241(12):1281-95. PubMed ID: 27022139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysregulation of glucose transport, glycolysis, TCA cycle and glutaminolysis by oncogenes and tumor suppressors in cancer cells.
    Chen JQ; Russo J
    Biochim Biophys Acta; 2012 Dec; 1826(2):370-84. PubMed ID: 22750268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased HIF1 alpha in SDH and FH deficient tumors does not cause microsatellite instability.
    Lehtonen HJ; Mäkinen MJ; Kiuru M; Laiho P; Herva R; van Minderhout I; Hogendoorn PC; Cornelisse C; Devilee P; Launonen V; Aaltonen LA
    Int J Cancer; 2007 Sep; 121(6):1386-9. PubMed ID: 17520677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncometabolites: tailoring our genes.
    Nowicki S; Gottlieb E
    FEBS J; 2015 Aug; 282(15):2796-805. PubMed ID: 25864878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The functional roles of TCA cycle metabolites in cancer.
    Eniafe J; Jiang S
    Oncogene; 2021 May; 40(19):3351-3363. PubMed ID: 33864000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Warburg effect increases steady-state ROS condition in cancer cells through decreasing their antioxidant capacities (anticancer effects of 3-bromopyruvate through antagonizing Warburg effect).
    El Sayed SM; Mahmoud AA; El Sawy SA; Abdelaal EA; Fouad AM; Yousif RS; Hashim MS; Hemdan SB; Kadry ZM; Abdelmoaty MA; Gabr AG; Omran FM; Nabo MM; Ahmed NS
    Med Hypotheses; 2013 Nov; 81(5):866-70. PubMed ID: 24071366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Krebs cycle dysfunction shapes epigenetic landscape of chromatin: novel insights into mitochondrial regulation of aging process.
    Salminen A; Kaarniranta K; Hiltunen M; Kauppinen A
    Cell Signal; 2014 Jul; 26(7):1598-603. PubMed ID: 24704120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cells silenced for SDHB expression display characteristic features of the tumor phenotype.
    Cervera AM; Apostolova N; Crespo FL; Mata M; McCreath KJ
    Cancer Res; 2008 Jun; 68(11):4058-67. PubMed ID: 18519664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.